Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Teriparatide Biosimilar (Shanghai Duomirui Biotechnology Co., Ltd.), 特立帕肽生物类似药(Shanghai Duomirui Biotechnology Co., Ltd.) |
Target |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis, Postmenopausal | IND Approval | CN | 08 Oct 2024 |